No Detail Found!

Expression of Serum Anti-BP180/230 Antibodies in Bullous Pemphigoid Patients Combined with Nervous System Diseases and Relevant Factor Analysis

Author(s)
Guili Liu Department of Neurology, Cangzhou People s Hospital,Cangzhou, Hebei,China
Bingnan Li Department of Neurology, Cangzhou People s Hospital,Cangzhou, Hebei,China
Zishen Zhao Department of Neurology, Cangzhou People s Hospital,Cangzhou, Hebei,China
Lanying Qin Department of Neurology, Cangzhou People s Hospital,Cangzhou, Hebei,China
Yuanying Zhao Department of Neurology, Cangzhou People s Hospital,Cangzhou, Hebei,China
Shuo Fang Department of Neurology, Cangzhou People s Hospital,Cangzhou, Hebei,China
Abstract
Objective: To explore the anti-BP230/180 and anti-BP180 antibodies in patients with bullous pemphigoid (BP) combined with neurological diseases, and to analyse the relevant factors. Study Design: Analytical study. Place and Duration of the Study: Neurology Department, Cangzhou People s Hospital, Cangzhou, from April 2019 to June 2022. Methodology: Eighty BP patients were chosen based on associated neurological diseases, they were split into single (n=42) and combined groups (n=38). Expression of anti-BP180/230 antibodies was compared between the two groups. Associations with neurological diseases were analysed and the factors a ecting the expression of anti-BP180/230 antibodies were explored. Results: Out of 80 patients, 61 were positive for anti-BP180 antibodies and 58 were positive for anti-BP230 antibodies. The proportion of patients with positive anti-BP230/180 antibodies in the single group was considerably lower than in the combined group (p100 IU/ml), and EOS count >0.5 x 91/L0 (p<0.05). Logistic analysis demonstrated that age, total IgE and EOS count were independent risk factors a ecting the expression of anti-BP180 and anti-BP23 antibodies (p<0.05). Conclusion: Serum anti-BP230/180 antibodies expression is abnormally high in BP patients having nervous system diseases. Combined nervous system diseases, age, total IgE and EOS count are independent risk factors a ecting expression of anti-BP180/230 antibodies.
Publication Details
Page(s) 141-145
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 34, Issue: 2, Year: 2024

Request the full text from PASTIC

Keywords
Bullous pemphigoid, bullous pemphigoid, Anti-BP230 antibody, Anti-BP180 antibody, Nervous system diseases
0

Citations

0

Downloads

93

Views